Relation of Smoking Status to Serum Levels of N-Terminal Pro–Brain Natriuretic Peptide in Middle-Aged Men Without Overt Cardiovascular Disease
Authors:
- 1 November 2010
- journal article
- Published by Elsevier in The American Journal of Cardiology
- Vol. 106 (10) , 1456-1460
Abstract
No abstract availableKeywords
Funding Information
- Japan Cardiovascular Research Foundation
This publication has 23 references indexed in Scilit:
- NT-proBNP testing for diagnosis and short-term prognosis in acute destabilized heart failure: an international pooled analysis of 1256 patientsEuropean Heart Journal, 2005
- Brain natriuretic peptide and n-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breathJACC, 2003
- Rapid Measurement of B-Type Natriuretic Peptide in the Emergency Diagnosis of Heart FailureNew England Journal of Medicine, 2002
- Value of plasma B type natriuretic peptide measurement for heart disease screening in a Japanese populationHeart, 2002
- Measurement of plasma brain natriuretic peptide level as a guide for cardiac overloadCardiovascular Research, 2001
- Value of natriuretic peptides in assessment of patients with possible new heart failure in primary careThe Lancet, 1997
- Plasma brain natriuretic peptide in assessment of acute dyspnoeaThe Lancet, 1994
- Mechanisms of atrial and brain natriuretic peptide release from rat ventricular myocardium: effect of stretching.Endocrinology, 1993
- Expression of A-, B-, and C-type natriuretic peptide genes in failing and developing human ventricles. Correlation with expression of the Ca(2+)-ATPase gene.Circulation Research, 1992
- Natriuretic peptides as cardiac hormones in normotensive and spontaneously hypertensive rats. The ventricle is a major site of synthesis and secretion of brain natriuretic peptide.Circulation Research, 1991